Jacobs & CO Pfizer Inc Transaction History

Jacobs & CO

$1 Billion
Q3 2024

A detailed history of Jacobs & CO transactions in Pfizer Inc stock. As of the latest transaction made, Jacobs & CO holds 288,362 shares of PFE stock, worth $7.92 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

288,362

Previous 321,460 10.3%

Holding current value

$7.92 Million

Previous $8.99 Million 7.22%

% of portfolio

0.83%

Previous 0.94%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$27.7 - $31.39 $916,814 - $1.04 Million	-33,098 Reduced 10.3%	288,362 $8.35 Million
Q2 2024 Jul 12, 2024	SELL	$25.26 - $29.6 $399,688 - $468,360	-15,823 Reduced 4.69%	321,460 $8.99 Million
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $187,961 - $215,839	7,260 Added 2.2%	337,283 $9.36 Million
Q4 2023 Jan 17, 2024	BUY	$26.13 - $33.94 $135,614 - $176,148	5,190 Added 1.6%	330,023 $9.5 Million
Q3 2023 Oct 13, 2023	BUY	$32.09 - $37.51 $230,181 - $269,059	7,173 Added 2.26%	324,833 $10.8 Million
Q2 2023 Jul 11, 2023	SELL	$36.12 - $41.79 $245,399 - $283,921	-6,794 Reduced 2.09%	317,660 $11.7 Million
Q1 2023 Apr 17, 2023	BUY	$39.39 - $51.28 $152,636 - $198,710	3,875 Added 1.21%	324,454 $13.2 Million
Q4 2022 Jan 13, 2023	BUY	$41.75 - $54.5 $5,177 - $6,758	124 Added 0.04%	320,579 $16.4 Million
Q3 2022 Oct 11, 2022	BUY	$43.76 - $53.42 $365,483 - $446,163	8,352 Added 2.68%	320,455 $14 Million
Q2 2022 Jul 19, 2022	SELL	$46.53 - $55.17 $62,489 - $74,093	-1,343 Reduced 0.43%	312,103 $16.4 Million
Q1 2022 Apr 14, 2022	SELL	$45.75 - $56.69 $199,332 - $246,998	-4,357 Reduced 1.37%	313,446 $16.2 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $46,567 - $69,028	1,127 Added 0.36%	317,803 $18.8 Million
Q3 2021 Oct 13, 2021	BUY	$39.25 - $50.42 $346,342 - $444,906	8,824 Added 2.87%	316,676 $13.6 Million
Q2 2021 Jul 15, 2021	BUY	$35.91 - $40.68 $231,044 - $261,735	6,434 Added 2.13%	307,852 $12.1 Million
Q1 2021 Apr 05, 2021	BUY	$33.49 - $37.77 $668,795 - $754,266	19,970 Added 7.1%	301,418 $10.9 Million
Q4 2020 Jan 12, 2021	BUY	$33.47 - $42.56 $274,554 - $349,119	8,203 Added 3.0%	281,448 $10.4 Million
Q3 2020 Dec 03, 2020	BUY	$31.75 - $37.25 $2.21 Million - $2.59 Million	69,587 Added 34.17%	273,245 $10 Million
Q2 2020 Jul 09, 2020	BUY	$30.12 - $36.54 $784,957 - $952,268	26,061 Added 14.67%	203,658 $6.66 Million
Q1 2020 Apr 13, 2020	SELL	$27.03 - $38.62 $131,230 - $187,500	-4,855 Reduced 2.66%	177,597 $5.8 Million
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $252,101 - $286,102	7,658 Added 4.38%	182,452 $7.15 Million
Q3 2019 Nov 04, 2019	SELL	$32.49 - $42.13 $125,996 - $163,380	-3,878 Reduced 2.17%	174,794 $6.28 Million
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $21,818 - $24,496	-590 Reduced 0.33%	178,672 $7.74 Million
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $129,712 - $142,510	-3,459 Reduced 1.89%	179,262 $7.61 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $194,158 - $221,361	-5,047 Reduced 2.69%	182,721 $7.98 Million
Q3 2018 Oct 23, 2018	SELL	$34.47 - $41.81 $289,099 - $350,660	-8,387 Reduced 4.28%	187,768 $8.27 Million
Q2 2018 Jul 19, 2018	SELL	$32.98 - $35.16 $83,901 - $89,447	-2,544 Reduced 1.28%	196,155 $7.12 Million
Q1 2018 Apr 30, 2018	SELL	$31.91 - $37.02 $24,889 - $28,875	-780 Reduced 0.39%	198,699 $7.05 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $47,628 - $50,535	-1,432 Reduced 0.71%	199,479 $7.23 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $6.23 Million - $6.86 Million	200,911	200,911 $7.17 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account